6533b86cfe1ef96bd12c8b31

RESEARCH PRODUCT

Eosinophil depletion suppresses radiation-induced small intestinal fibrosis.

Yutaka SuzukiLamichhane AayamSatoshi KanetoKen IshiiYusuke TamuraShizuo AkiraYosuke KurashimaMasaki MoriM.e. RothenbergDaichi KobayashiTakayuki OginoTakayuki OginoYutaro KumagaiNaoki TakemuraNaoki TakemuraShintaro SatoShintaro SatoHiroshi KiyonoHiroshi KiyonoKazuki OkadaKouta MatsunagaHideki OsawaSatoshi UematsuSatoshi UematsuYuki MoriHirosih MatsunoJunichi NishimuraYasuo OuchiEun Jeong ParkEun Jeong ParkYoshichika Yoshioka

subject

0301 basic medicineChemokineStromal cellCCR303 medical and health sciencesChemokine receptorMiceIntestine SmallmedicineAnimalsIntestinal MucosaReceptorCCL11biologyChemistryGeneral Medicinerespiratory systemEosinophilFibrosisSmall intestineEosinophilsDisease Models AnimalRadiation Injuries Experimental030104 developmental biologymedicine.anatomical_structurebiology.proteinCancer research

description

Radiation-induced intestinal fibrosis (RIF) is a serious complication after abdominal radiotherapy for pelvic tumor or peritoneal metastasis. Herein, we show that RIF is mediated by eosinophil interactions with α-smooth muscle actin-positive (α-SMA+) stromal cells. Abdominal irradiation caused RIF especially in the submucosa (SM) of the small intestine, which was associated with the excessive accumulation of eosinophils in both human and mouse. Eosinophil-deficient mice showed markedly ameliorated RIF, suggesting the importance of eosinophils. After abdominal irradiation, chronic crypt cell death caused elevation of extracellular adenosine triphosphate, which in turn activated expression of C-C motif chemokine 11 (CCL11) by pericryptal α-SMA+ cells in the SM to attract eosinophils in mice. Inhibition of C-C chemokine receptor 3 (CCR3) by genetic deficiency or neutralizing antibody (Ab) treatment suppressed eosinophil accumulation in the SM after irradiation in mice, suggesting a critical role of the CCL11/CCR3 axis in the eosinophil recruitment. Activated α-SMA+ cells also expressed granulocyte-macrophage colony-stimulating factor (GM-CSF) to activate eosinophils. Transforming growth factor-β1 from GM-CSF-stimulated eosinophils promoted collagen expression by α-SMA+ cells. In translational studies, treatment with a newly developed interleukin-5 receptor α-targeting Ab, analogous to the human agent benralizumab, depleted intestinal eosinophils and suppressed RIF in mice. Collectively, we identified eosinophils as a crucial factor in the pathogenesis of RIF and showed potential therapeutic strategies for RIF by targeting eosinophils.

10.1126/scitranslmed.aan0333https://pubmed.ncbi.nlm.nih.gov/29467297